KMC Speciality Hospitals Intrinsic Value
KMCSHIL Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹26.03 | ₹20.82 - ₹31.24 | -70.0% | EPS: ₹1.90, Sector P/E: 12x |
| Book Value Method | asset | ₹102.50 | ₹92.25 - ₹112.75 | +18.1% | Book Value/Share: ₹102.50, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹134.00 | ₹120.60 - ₹147.40 | +54.4% | Revenue/Share: ₹167.50, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹173.52 | ₹156.17 - ₹190.87 | +100.0% | EBITDA: ₹73.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹216.90 | ₹173.52 - ₹260.28 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹26.03 | ₹23.43 - ₹28.63 | -70.0% | EPS Growth: 7.0%, Fair P/E: 5.6x |
| Growth Adjusted P/E | growth | ₹26.03 | ₹23.43 - ₹28.63 | -70.0% | Revenue Growth: 15.0%, Adj P/E: 8.6x |
| ROE Based Valuation | profitability | ₹173.52 | ₹156.17 - ₹190.87 | +100.0% | ROE: 18.3%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹66.20 | ₹59.58 - ₹72.82 | -23.7% | EPS: ₹1.90, BVPS: ₹102.50 |
Want to compare with current market value? Check KMCSHIL share price latest .
Valuation Comparison Chart
KMCSHIL Intrinsic Value Analysis
What is the intrinsic value of KMCSHIL?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of KMC Speciality Hospitals (KMCSHIL) is ₹102.50 (median value). With the current market price of ₹86.76, this represents a +18.1% variance from our estimated fair value.
The valuation range spans from ₹26.03 to ₹216.90, indicating ₹26.03 - ₹216.90.
Is KMCSHIL undervalued or overvalued?
Based on our multi-method analysis, KMC Speciality Hospitals (KMCSHIL) appears to be trading below median value by approximately 18.1%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.39 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 1.74 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 18.3% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 26.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.94x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for KMC Speciality Hospitals
Additional stock information and data for KMCSHIL
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹58 Cr | ₹33 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹38 Cr | ₹10 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹32 Cr | ₹8 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹29 Cr | ₹15 Cr | Positive Free Cash Flow | 7/10 |
| March 2021 | ₹26 Cr | ₹5 Cr | Positive Free Cash Flow | 7/10 |